Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

392 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of high-resolution matching in allogeneic unrelated donor stem cell transplantation in Switzerland.
Chalandon Y, Tiercy JM, Schanz U, Gungor T, Seger R, Halter J, Helg C, Chapuis B, Gratwohl A, Tichelli A, Nicoloso de Faveri G, Roosnek E, Passweg JR; Swiss Transplant Working Group for Blood and Marrow Transplantation (STABMT); Swiss National Donor Registry. Chalandon Y, et al. Among authors: gungor t. Bone Marrow Transplant. 2006 May;37(10):909-16. doi: 10.1038/sj.bmt.1705353. Bone Marrow Transplant. 2006. PMID: 16565739
High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities.
Passweg JR, Schanz U, Chalandon Y, Güngör T, Baldomero H, Heim D, Nair G, Medinger M, Masouridi-Levrat S, de Faveri GN, Tiercy JM; Swiss Blood Stem Cell Transplantation Group. Passweg JR, et al. Among authors: gungor t. Bone Marrow Transplant. 2015 Sep;50(9):1201-5. doi: 10.1038/bmt.2015.129. Epub 2015 Jun 8. Bone Marrow Transplant. 2015. PMID: 26052916
The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT.
Marek A, Stern M, Chalandon Y, Ansari M, Ozsahin H, Güngör T, Gerber B, Kühne T, Passweg JR, Gratwohl A, Tichelli A, Seger R, Schanz U, Halter J, Stussi G; Swiss Blood Stem Cell Transplantation. Marek A, et al. Among authors: gungor t. Bone Marrow Transplant. 2014 Jan;49(1):55-61. doi: 10.1038/bmt.2013.132. Epub 2013 Sep 16. Bone Marrow Transplant. 2014. PMID: 24037023
A phase II trial of liposomal busulphan as an intravenous myeloablative agent prior to stem cell transplantation: 500 mg/m(2) as a optimal total dose for conditioning.
Hassan M, Nilsson C, Hassan Z, Gungor T, Aschan J, Winiarski J, Hentschke P, Ringdén O, Eber S, Seger R, Ljungman P. Hassan M, et al. Among authors: gungor t. Bone Marrow Transplant. 2002 Dec;30(12):833-41. doi: 10.1038/sj.bmt.1703739. Bone Marrow Transplant. 2002. PMID: 12476274 Clinical Trial.
The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG.
Dalle JH, Balduzzi A, Bader P, Pieczonka A, Yaniv I, Lankester A, Bierings M, Yesilipek A, Sedlacek P, Ifversen M, Svec P, Toporski J, Gungor T, Wachowiak J, Glogova E, Poetschger U, Peters C. Dalle JH, et al. Among authors: gungor t. Bone Marrow Transplant. 2021 Jan;56(1):257-266. doi: 10.1038/s41409-020-01014-x. Epub 2020 Aug 4. Bone Marrow Transplant. 2021. PMID: 32753706 Free PMC article.
392 results